AzTrials
AzTrials

Hip OsteoarthritisNCT05100966

FitJoints: Getting Fit for Hip and Knee Replacement

A study testing FitJoints Multi-modal Intervention in people with Hip Osteoarthritis and Knee Osteoarthritis, run by McMaster University at 4 sites in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Total hip or knee replacement is an important and cost-effective surgical intervention to relieve pain and improve independence and function in patients with osteoarthritis. The number of people waiting for elective surgeries has spiked in the COVID-19 pandemic. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Hip Osteoarthritis, Knee Osteoarthritis
What is being tested?
FitJoints Multi-modal Intervention
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
192 participants
Where
4 sitesCanada
Study dates
14 Jun 2022to Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Pre-frail (score of 1 or 2) or frail (score of 3-5)
  • ≥ 60 years old
  • Receiving elective unilateral total hip or knee replacement
  • Waiting time for surgery is estimated to be between 4 to 15 months

Who cannot join

  • Renal disorder
  • A neuromuscular disorder
  • Active cancer
  • Inflammatory arthritis
  • Unable to speak or understand English and has no caregiver for translation
  • Participating in another trial that involves protein supplementation
  • Participating in an exercise program

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Alexandra Papaioannou, MD, MSc contact

(905) 521-2100 ext. 77715

papaioannou@hhsc.ca

George Ioannidis, MSc, PhD contact

ioannidis@hhsc.ca

Canada4 sites, 4 recruiting
  • Foothill Medical Centre - Alberta Health Services

    Calgary, Alberta

    Prism Schneider, MD, FRCSC

    Not yet recruiting
  • Juravinski Hospital - Hamilton Health Sciences

    Hamilton, Ontario

    Mitchell Winemaker, MD, FRCSC

    Recruiting
  • St. Joseph's Healthcare

    Hamilton, Ontario

    Anthony Adili, MD, FRCSC

    Not yet recruiting
  • University Hospital - London Health Sciences Centre

    London, Ontario

    Emil Schemitsch, MD, FRCSC

    Not yet recruiting

Other trials in Canada

About this study

Official title: Getting Fit for Hip and Knee Replacement: The FitJoints Multisite Randomized Controlled Trial of a Multi-modal Intervention in Frail Patients With Osteoarthritis

Total hip or knee replacement is an important and cost-effective surgical intervention to relieve pain and improve independence and function in patients with osteoarthritis. The number of people waiting for elective surgeries has spiked in the COVID-19 pandemic. Prior to COVID-19, up to 40% of patients receiving joint replacement were frail and this number is rapidly increasing with longer wait-times and deconditioning associated with COVID-19 physical distancing. There is an urgent need to be responsive to the evolving challenges of healthcare. The proposed study is the first multi-site randomized controlled trial (RCT) to examine whether a multimodal frailty reduction intervention before surgery will improve postsurgical outcomes for this population. The COVID-19 adapted hybrid model includes a multimodal frailty intervention that may be implemented either in person or virtually and is aligned with international consensus guidelines on frailty reduction.

To utilize the FitJoints multimodal frailty intervention to build resilience of patients undergoing joint replacement surgery to improve post-operative outcomes. The investigators hypothesize the FitJoints multimodal frailty intervention, with exercise, nutrition and medication optimization, will reduce frailty and pain while improving function and quality of life.

Read more

Building upon the success of the FitJoints feasibility study (n=69) in Hamilton, Ontario, in the proposed multi-site RCT (n=192), older adults (≥60 years) undergoing hip or knee joint replacement surgery who are frail will be randomized to either the 3 to 6-months of multimodal intervention or usual care until the date of their surgery at multiple sites (Hamilton Health Sciences \& St Joseph's Healthcare Hamilton, ON; London Health Science Centre, London, ON; Foothills Hospital, Calgary, AB),The FitJoints evidence-based, multimodal intervention includes a hybrid model that can be implemented either in person or virtually:

  1. Physiotherapist supported multi-component exercise program
  2. Nutrition and protein optimization including dietary counseling
  3. Medication review with prescribing recommendations
Being tested
FitJoints Multi-modal Intervention
Keywords
Frail elderly, Arthroplasty, Pre-rehabilitation
Medical subject headings
Osteoarthritis, Hip, Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FitJoints Multi-modal InterventionOther

    Exercise: The study physiotherapist will prescribe an exercise program tailored to the participant's individual ability and preference with functional movements to mimic activities of daily living.

    Nutritional consultation and protein supplement: The site research assistant will coach participants to improve their nutrition, determine their daily protein target, and provide educational tools on how to achieve their target. Protein supplements will be provided to participants.

    Vitamin D: Participants will be provided with vitamin D3 (1000 IU) tablets to reduce the risk of falls and to preserve muscle strength and functional ability. They will be instructed to take one tablet daily for the duration of the intervention period.

    Medication optimization: The study pharmacist will conduct a medication review and provide, if required, recommendations for medication optimization.

Study groups in NCT05100966
Study groupRoleWhat they receive
Usual CareNo interventionParticipants in the control arm will receive usual care which involves patient education that all participants who are scheduled for hip/knee replacement receive at the arthroplasty centre. This may include recommendations to attend fitness classes or discuss nutrition tips and smoking cessation initiatives with their family doctor or other healthcare provider before surgery.
FitJoints Multi-modal InterventionActive comparatorNot described
Receives: Other: FitJoints Multi-modal Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Between-group Difference in Physical Performance

    Assessed by the Short Physical Performance Battery (SPPB), which consists of the following sub-components:

    • 4-meter walk test (walking speed): measured in seconds, scored 0 to 4
    • Chair rise: the ability to rise from a chair without arms: measured in seconds, scored 0 to 4
    • Standing balance test: measured in seconds, scored 0 to 4

    Sub-component scores will be aggregated to produce an overall SPPB score, with higher scores indicating lower level of frailty [range 0-12].

    Measured: 3-months post-operative

Secondary outcomes (13)
  1. Between-group Difference in Frailty

    Assessed by the Fit-Frailty Index. Higher scores indicate greater degree of frailty [range 0-1].

    Measured: 3-months post-operative

  2. Between-group Difference in Knee Function/Pain

    Patient-reported knee function/pain, assessed by the Oxford Knee Score. Higher scores indicate better knee functionality [range 0-48].

    Measured: 3-months post-operative

  3. Between-group Difference in Hip Function/Pain

    Patient-reported hip function/pain, assessed by the Oxford Hip Score. Higher scores indicate better hip functionality [range 0-48].

    Measured: 3-months post-operative

  4. Between-Group Difference in Instrumental Activities of Daily Living

    Ability to carry out instrumental activities of daily living as operationalized by the Older American Resources \& Services (OARS) questionnaire. Higher scores indicate greater ability to perform instrumental activities of daily living [range 0-14].

    Measured: 3-months post-operative

  5. Between-group Difference in Physical Activities of Daily Living

    Ability to carry out physical activities of daily living as operationalized by the Older American Resources \& Services (OARS) questionnaire. Higher scores indicate greater ability to perform physical activities of daily living [range 0-14].

    Measured: 3-months post-operative

  6. Between-group difference in Sarcopenia

    Assessed by the SARC-F - Self-reported strength, assistance with walking, rising from a chair, climbing stairs and falls. Higher scores indicate greater level of sarcopenia, with scores equal to or greater than 4 predictive of sarcopenia and poorer outcomes [range 0-10].

    Measured: 3-months post-operative

  7. Between-group Difference in Nutrition

    Assessed by the Mini Nutritional Assessment (MNA). Higher scores indicate better nutritional status (<17 malnourished, 17-23.5 at risk of malnutrition, 24-30 normal nutritional status) [range 0-30].

    Measured: 3-months post-operative

  8. Between-group Difference in Cognition

    Ottawa-3DY-cognitive assessment - recall of day of week, date, year, spell WORLD backwards. Score of 4 indicates normal mental status, <4 indicates impaired mental status [range 0-4].

    Measured: 3-months post-operative

  9. Between-group Difference in Health-Related Quality of Life

    Quality of life questionnaire (EQ-5D-5L) which consists of 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.

    Each dimension in the EQ-5D-5L has five response levels: no problems (Level 1); slight; moderate; severe; and extreme problems (Level 5). There are 3,125 possible health states defined by combining one level from each dimension, ranging from 11111 (full health) to 55555 (worst health).

    Measured: 3-months post-operative

  10. Between-group Difference in Number of Hospitalizations

    Number of hospitalizations will be recorded. Higher numbers of hospitalizations indicates higher healthcare utilization.

    Measured: 3-months post-operative

  11. Between-group Difference in Number of Emergency Department Visits

    Number of emergency department visits will be recorded. Higher number of emergency department visits indicates higher healthcare utilization.

    Measured: 3-months post-operative

  12. Between-group Difference in Number of Visits to Physicians/Healthcare Professionals

    Number of visits to physicians and other healthcare professionals will be recorded. Higher number of visits indicates higher healthcare utilization.

    Measured: 3-months post-operative

  13. Between-group Difference in Number of Post-operative Complications

    Any post-op complications (e.g. number of infections, peri-prosthetic fractures, bleeding) will be recorded.

    Measured: 3-months post-operative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2021
  2. Study start14 Jun 2022
  3. Primary completionMar 2026 (estimated)
  4. Study completionMar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
192 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05100966
Sponsor's protocol ID
3732
Status last verified
Jun 2025
First submitted
27 Sep 2021
Last updated
1 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing FitJoints Multi-modal Intervention in people with Hip Osteoarthritis and Knee Osteoarthritis, run by McMaster University at 4 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alexandra Papaioannou, MD, MSc ((905) 521-2100 ext. 77715, papaioannou@hhsc.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Between-group Difference in Physical Performance (time frame: 3-months post-operative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in